A new era in the diagnosis and treatment of tardive dyskinesia

Tardive dyskinesia (TD) is a heterogeneous, hyperkinetic movement disorder induced by dopamine-receptor blocking agents that presents a unique challenge in the treatment of psychosis. Although acceptance of TD as a serious consequence of antipsychotic treatment was resisted initially, subsequent res...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS spectrums 2023-08, Vol.28 (4), p.401-415
1. Verfasser:	Caroff, Stanley N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Antipsychotics CME Review Diabetes Dopamine Drug dosages Dyskinesia Dystonia Emotional disorders Humans Mood disorders Movement disorders Patients Phenomenology Prescription drugs Psychotropic drugs Risk factors Schizophrenia Tardive Dyskinesia - chemically induced Tardive Dyskinesia - diagnosis Tardive Dyskinesia - drug therapy Tardive Dyskinesia - therapy Vesicular Monoamine Transport Proteins - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!